Scientists have discovered how HIV virus avoids elimination from the immune system, a finding which could pave the way for the cure for over 40 million people infected worldwide.
Currently, HIV can be treated with anti-retroviral therapy, which merely prevents its progression to AIDS, but does not offer the cure.
The researchers found that HIV virus blocks a pathway and thus avoids the immune response that is designed to cure the viral infection.
"Our new revelation sheds new light on how HIV avoids elimination, which, in turn, may explain why HIV is still not a curable disease," said Nigel Stevenson, Assistant Professor in Immunology at Trinity College Dublin.
"We feel this discovery could mark a paradigm shift in our understanding of how this virus evades our immune response. It should open the door to a new era of HIV research aiming to cure and eradicate this deadly virus," Stevenson added, in a paper published in the journal EBioMedicine.
During any viral infection, our immune system produces a powerful molecule called as interferon, which "interferes" with the infection and the replication of viruses.
Interferon activates an assembly line of molecules in our cells -- via the Interferon signalling pathway -- which causes the body to make antivirals that help to clear the infection.
But HIV somehow blocks the Interferon signalling pathway. Thus, when patients are being treated with anti-retroviral therapy, HIV is not fully cleared by our immune system, the researchers found.
"We discovered that HIV promotes the destruction of the anti-viral Interferon signalling pathway. Essentially, HIV uses the machinery in our own cells to do this, and the virus is thus able to reduce the production of many important anti-viral molecules," said Stevenson.
"Without these anti-viral molecules, our immune system can't clear viral infections," he noted.
--IANS
rt/and/mr
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
